Header Logo

Connection

Arnold Seto to Percutaneous Coronary Intervention

This is a "connection" page, showing publications Arnold Seto has written about Percutaneous Coronary Intervention.
Connection Strength

19.132
  1. Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results? Circulation. 2024 Aug 20; 150(8):598-599.
    View in: PubMed
    Score: 0.828
  2. Virtual FFR From Optical Coherence Tomography: A 1-Stop Shop for PCI Guidance? Circ Cardiovasc Interv. 2024 Apr; 17(4):e014077.
    View in: PubMed
    Score: 0.805
  3. Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery? Catheter Cardiovasc Interv. 2024 Apr; 103(5):826-827.
    View in: PubMed
    Score: 0.804
  4. Can We Predict Who Will Have Angina Relief From Percutaneous Coronary Intervention? Circ Cardiovasc Interv. 2023 04; 16(4):e013020.
    View in: PubMed
    Score: 0.751
  5. Better together? Maybe not with CTO-PCI. Catheter Cardiovasc Interv. 2023 03; 101(4):828-829.
    View in: PubMed
    Score: 0.748
  6. The future of angiography: Estimates of FFR pre- and post-PCI. Catheter Cardiovasc Interv. 2022 12; 100(7):1218-1219.
    View in: PubMed
    Score: 0.735
  7. Closing the loop in cath lab communication: Avoiding the tower of babble. Catheter Cardiovasc Interv. 2022 06; 99(7):1963-1964.
    View in: PubMed
    Score: 0.710
  8. Physiologic Lesion Assessment to Optimize Multivessel Disease. Curr Cardiol Rep. 2022 05; 24(5):541-550.
    View in: PubMed
    Score: 0.698
  9. Clinical risk overlaps both bare metal and drug-eluting stents. Catheter Cardiovasc Interv. 2022 02; 99(3):552-553.
    View in: PubMed
    Score: 0.694
  10. How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al. Catheter Cardiovasc Interv. 2021 02 01; 97(2):257-258.
    View in: PubMed
    Score: 0.647
  11. Predicting post stent fractional flow reserve virtually from quantitative flow ratio - Can we really get there from here? Catheter Cardiovasc Interv. 2020 11; 96(6):1154-1155.
    View in: PubMed
    Score: 0.636
  12. Does "Myocardial Injury" Matter Post-PCI? JACC Cardiovasc Interv. 2019 10 14; 12(19):1963-1965.
    View in: PubMed
    Score: 0.591
  13. What patients want. Catheter Cardiovasc Interv. 2019 06 01; 93(7):1244-1245.
    View in: PubMed
    Score: 0.576
  14. The calculus of preloading antiplatelet agents in ST-elevation myocardial infarction: Does it make a difference? Catheter Cardiovasc Interv. 2019 03 01; 93(4):602-603.
    View in: PubMed
    Score: 0.566
  15. Clinical Outcomes Data for Instantaneous Wave-Free Ratio-Guided Percutaneous Coronary Intervention. Interv Cardiol Clin. 2019 04; 8(2):121-129.
    View in: PubMed
    Score: 0.563
  16. Caution! You're approaching a gray zone: FFR outcomes and the role of CFR and IMR. Catheter Cardiovasc Interv. 2018 11 15; 92(6):1088-1089.
    View in: PubMed
    Score: 0.555
  17. Why does FFR-guided PCI improve clinical outcomes? The missing link of post-PCI ischemia reduction. Catheter Cardiovasc Interv. 2018 10 01; 92(4):701-702.
    View in: PubMed
    Score: 0.550
  18. Newsflash, PCI Works: Stenting Stenoses Increases Coronary Blood Flow During Exercise and Reduces Ischemia. J Am Coll Cardiol. 2018 08 28; 72(9):984-986.
    View in: PubMed
    Score: 0.547
  19. Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions. Catheter Cardiovasc Interv. 2018 10 01; 92(4):717-731.
    View in: PubMed
    Score: 0.534
  20. Instantaneous Wave-Free Ratio Pressure Pullback With Virtual Percutaneous Coronary Intervention Planning: Seeing the Future of Coronary Interventions? JACC Cardiovasc Interv. 2018 04 23; 11(8):768-770.
    View in: PubMed
    Score: 0.534
  21. Early stent thrombosis: Nearly gone, but never forgotten. Catheter Cardiovasc Interv. 2018 04 01; 91(5):849-850.
    View in: PubMed
    Score: 0.532
  22. Does the AToMIC trial explode concerns of contrast coagulopathy? Catheter Cardiovasc Interv. 2016 Nov; 88(5):738-739.
    View in: PubMed
    Score: 0.482
  23. Why we need intravenous antiplatelet agents. Future Cardiol. 2016 09; 12(5):553-61.
    View in: PubMed
    Score: 0.468
  24. Antiplatelet agents in transradial primary PCI: safe enough to be aggressive. Coron Artery Dis. 2016 06; 27(4):255-6.
    View in: PubMed
    Score: 0.468
  25. Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA. Catheter Cardiovasc Interv. 2016 Jun; 87(7):1224-30.
    View in: PubMed
    Score: 0.460
  26. Coronary perforation: What color is your parachute? Catheter Cardiovasc Interv. 2015 Sep; 86(3):405-6.
    View in: PubMed
    Score: 0.445
  27. 38 mm Stents: go big and go long. Catheter Cardiovasc Interv. 2015 Feb 01; 85(2):225-6.
    View in: PubMed
    Score: 0.427
  28. Direct stenting for STEMI: does it really make a difference? Catheter Cardiovasc Interv. 2014 Nov 15; 84(6):932-3.
    View in: PubMed
    Score: 0.421
  29. Are veterans and the VA any more "crusty" than others? Catheter Cardiovasc Interv. 2014 Oct 01; 84(4):644-5.
    View in: PubMed
    Score: 0.417
  30. Glycoprotein inhibitors: not dead yet. Catheter Cardiovasc Interv. 2013 Aug 01; 82(2):182-3.
    View in: PubMed
    Score: 0.385
  31. Microvascular Resistance Reserve and?the?STEMI Patient: Putting a Finer Point on the CFR Pencil? JACC Cardiovasc Interv. 2024 May 27; 17(10):1228-1230.
    View in: PubMed
    Score: 0.203
  32. Changes in post-PCI physiology based on anatomical vessel location: a DEFINE PCI substudy. EuroIntervention. 2023 Dec 18; 19(11):e903-e912.
    View in: PubMed
    Score: 0.198
  33. 1-Year Outcomes of Blinded Physiological Assessment of Residual?Ischemia After Successful PCI: DEFINE PCI Trial. JACC Cardiovasc Interv. 2022 01 10; 15(1):52-61.
    View in: PubMed
    Score: 0.173
  34. Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank. Catheter Cardiovasc Interv. 2020 11; 96(6):1258-1265.
    View in: PubMed
    Score: 0.157
  35. Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2020 11; 21(11):1360-1368.
    View in: PubMed
    Score: 0.154
  36. Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary?Intervention: The DEFINE PCI Study. JACC Cardiovasc Interv. 2019 10 28; 12(20):1991-2001.
    View in: PubMed
    Score: 0.148
  37. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2019 09 01; 4(9):857-864.
    View in: PubMed
    Score: 0.147
  38. Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes. J Am Heart Assoc. 2019 01 22; 8(2):e010373.
    View in: PubMed
    Score: 0.141
  39. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 05 11; 376(19):1824-1834.
    View in: PubMed
    Score: 0.124
  40. Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction and Concurrent Active Gastrointestinal Bleeding. Circ Cardiovasc Interv. 2015 Oct; 8(10).
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.